Tag: biosimilars
- Mar 11, 2026
- Posted by Cillian Osterfield
What Are Biosimilars? A Simple Guide for Patients
Biosimilars are highly similar versions of complex biologic drugs, approved by the FDA to work just like the original. They're not generics, but they're safe, effective, and often cheaper. Here's what patients need to know.
- Jan 22, 2026
- Posted by Cillian Osterfield
Future Economic Trends: Forecasts for Generic Drug Markets
Generic drug markets are set to grow to over $700 billion by 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India and China's manufacturing power, and tech-driven efficiency are reshaping global healthcare affordability.
